Market Update: BIIB, CHD, LH, HLN Yahoo Finance Market Update: BIIB, CHD, LH, HLN. Biogen (BIIB) Church&Dwight (CHD) 1 month
Biogen Inc.’s (BIIB) Morgan Stanley’s 22nd Annual Global Healthcare Conference Transcript Seeking Alpha 3 weeks
Biogen Stock Slips As Alzheimer’s Drug Looks Abroad For Quarterly Beat Investor's Business Daily 2 months
Biogen beats expectations, hikes outlook as Alzheimer’s drug and other new products gain traction CNBC 2 months
Biogen Stock Tumbles After European Regulators Unexpectedly Reject Alzheimer’s Drug Investor's Business Daily 2 months
The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen Agenus and BioMarin Pharmaceutical Zacks 2 months
Sage Therapeutics Collapses 21% After Biogen-Tied Essential Tremor Drug Fails Investor's Business Daily 2 months
Ionis Pharmaceuticals Surges Into Buy Zone As It, Possibly, Proves Biogen Wrong Investor's Business Daily 2 months
Eli Lilly Wins Long-Awaited Approval For Biogen-Rivaling Alzheimer’s Drug Investor's Business Daily 3 months
FDA Panelists Unanimously Back Eli Lilly’s Biogen-Rivaling Alzheimer’s Drug Investor's Business Daily 3 months
Church & Dwight: Waning Pricing Benefits And Valuation Concerns Keep Me On The Sidelines Seeking Alpha 4 months
Biogen to acquire privately held Human Immunology Biosciences for $1.15 billion upfront MarketWatch 4 months
Biogen Stock Continues Its 24% Sprint On A Twist In Alzheimer’s Treatment Investor's Business Daily 4 months